MedPath
NMPA Approval

Dapoxetine Hydrochloride Tablets

国药准字HJ20150564

May 31, 2024

H20150564

Drug Information

盐酸达泊西汀片

必利劲

片剂

60mg

化学药品

May 31, 2024

May 30, 2029

Company Information

Applicant Company

BERLIN-CHEMIE AG

Glienicker Weg 125 12489 Berlin Federal Republic of Germany

Manufacturing Company

menarini-von heyden gmbh

Leipziger Straβe 7-13 01097 Dresden Federal Republic of Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸达泊西汀片 - NMPA 批准文号 | MedPath